Novo Nordisk (NVO)
Novo Nordisks Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
Novo Nordisks Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial